NeuroMetrix Launches Website for painful diabetic neuropathy Education

NeuroMetrix Inc., a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, has launched a new website to provide patients and physicians with a location for information about chronic pain such as painful diabetic neuropathy (PDN). The website, www.SENSUSrx.com, also provides information about the company’s Sensus pain management system.

Sensus is a wearable, non-invasive electrical nerve stimulator that offers patients a purportedly fast-acting, non-narcotic option for relief from chronic pain. The device is lightweight and can be worn during the day while remaining active, or at night while sleeping. It is specifically designed for people with diabetes that suffer from chronic pain. The most common cause of such pain is PDN which affects up to 5 million people in the United States alone.

The website contains a variety of content including interactive tools to help people evaluate and discuss chronic pain with their physicians, video testimonials of Sensus users, and product support materials such as an instructional video. The website also contains social media features including a Sensus blog that reportedly points visitors to the latest relevant research and provide updates on Sensus and related technologies.

“This new website will provide patients and physicians easy access to information about chronic pain, such as PDN and the use of Sensus for pain relief,” said Shai N. Gozani M.D., Ph.D., president and CEO of NeuroMetrix. “PDN is a large problem in the diabetes community. We believe that there is an important role for Sensus to play in managing pain due to PDN, and that this website will be a useful tool to reach this audience. It contains a wide range of product and disease information that we intend to further expand over time.”

NeuroMetrix is a medical device company that develops and markets home use and point-of-care devices for the treatment and management of chronic pain, peripheral neuropathies, and associated neurological disorders. The company is headquartered in Waltham, Mass.